Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06581302
NA

Magnetic Seizure Therapy for Psychotic Disorders

Sponsor: Shanghai Jiao Tong University School of Medicine

View on ClinicalTrials.gov

Summary

This trial aims to evaluate the efficacy and safety of Magnetic Seizure Therapy (MST) as an augmentation of antipsychotic medications for psychosis.

Official title: Accelerated 100Hz Magnetic Seizure Therapy for Psychotic Disorders

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-09-01

Completion Date

2025-12-30

Last Updated

2025-11-25

Healthy Volunteers

No

Interventions

DEVICE

Magnetic seizure therapy by Magnetic stimulator

The seizure is induced by Magnetic stimulator of MagPro MST(XP),MagVenture A/S, Farum, Denmark. It is administered in combinations with antipsychotic medications

DRUG

Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc)

It mainly includes second-generation antipsychotic medications, such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc, but except clozapine.

Locations (2)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China